Veronica Gagliardi | microcirculation | Best Researcher Award

Dr. Veronica Gagliardi | microcirculation | Best Researcher Award

Dr. Veronica Gagliardi, Università degli studi di Padova, Italy

Dr. Veronica Gagliardi is an Italian Medical Doctor specializing in Anaesthesiology, Resuscitation, Intensive Care, and Pain Therapy. Born on August 22, 1996, in Spinea (VE), she is currently undergoing advanced clinical training at the University of Padua, where she has also undertaken a Level II Master in multimodal cardiac imaging. She combines academic excellence with frontline clinical experience in major regional hospitals, including Ospedale dell’Angelo in Mestre and Policlinico Universitario di Padova. Her work focuses on intensive care medicine, advanced echocardiography, and non-invasive ventilation strategies. Dr. Gagliardi is widely published, with a strong record in critical care, pain therapy, and ultrasound techniques. Her proactive involvement in clinical research and innovative therapies, including ECMO and auricular acupuncture, reflects a strong commitment to scientific advancement in patient care. She is a promising researcher and clinician, striving to integrate cutting-edge evidence with compassionate care.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Extensive Research Portfolio:
    Dr. Gagliardi has authored and co-authored over 10 peer-reviewed publications across respected international journals (Life, Medicina, Critical Care, Cureus, EJTM, Arch Clin Biomed Res), covering high-impact areas like ECMO, microcirculation, pain therapy, and non-invasive ventilation.

  2. Clinical-Research Integration:
    Her ability to bridge clinical practice and research is a standout quality. From ECMO and PEEP titration in COVID-19 to auricular electroacupuncture and ultrasound-guided pain procedures, she applies science directly to bedside care.

  3. Strong Academic Record:
    With a Medical Degree cum laude (110/110) and advanced training at the University of Padua, she demonstrates academic excellence, now furthered by a Level II Master in echocardiographic imaging.

  4. Leadership and Collaboration:
    She has actively participated in multi-center projects and international symposia, indicating both team leadership and scientific communication skills.

  5. Innovation and Versatility:
    Her research includes novel and multidisciplinary approaches—like capsaicin patch use for neuropathic pain and auricular diagnostics in oncology contexts.

⚙️ Areas for Improvement:

  1. Recognition and Awards:
    While her work is highly impactful, Dr. Gagliardi may benefit from more formal recognition, such as national/international fellowships, grants, or young investigator awards.

  2. Independent Research Funding:
    Securing her own research grants in the near future would further strengthen her research independence and global visibility.

  3. Broader Dissemination:
    Increasing her presence through conference presentations, keynote talks, or editorial roles would amplify the visibility of her work and boost her academic footprint.

🎓 Education:

Dr. Veronica Gagliardi earned her Master’s Degree in Medicine and Surgery with 110/110 with Honours from the University of Padua, completing an experimental thesis under Prof. Paolo Navalesi on respiratory failure in COVID-19 patients. Since November 2021, she has been enrolled in a five-year residency program in Anaesthesiology, Resuscitation, Intensive Care, and Pain Therapy at the same institution, with rotations in several prominent hospitals. Starting November 2024, she will also undertake a Level II Master (ESTAV) in stress echocardiography, advanced transesophageal, and multimodal cardiac imaging, focusing on perioperative and interventional cardiac ultrasound techniques. Her education reflects not only clinical rigor but also a keen interest in research and innovation, particularly in areas like non-invasive ventilation, ultrasound diagnostics, and pain modulation. Her academic background is complemented by strong scientific output and peer-reviewed contributions in high-impact journals.

💼 Professional Experience:

Dr. Gagliardi has held the role of Medical Doctor specializing in Anaesthesiology and Intensive Care at Ospedale dell’Angelo in Mestre, starting in January 2025. Initially assigned to general anaesthesiology (UOS), she has since progressed to the Cardiac Intensive Care Unit (UOS) from May 2025. Her residency training from November 2021 to January 2025 included rotations in premier institutions such as Policlinico Universitario di Padova, Ospedale S. Antonio, Ospedale Ca’ Foncello, and Ospedale SS Giovanni e Paolo, gaining experience in critical care, pain therapy, perioperative medicine, and emergency interventions. Throughout her career, she has consistently demonstrated clinical versatility, excelling in high-pressure ICU settings. She combines clinical competence with advanced procedural skills, including echocardiography and ultrasound-guided regional blocks. This diverse clinical exposure underpins her contribution to complex case management and patient-centered care.

🏅 Awards and Honors:

Dr. Veronica Gagliardi has not been explicitly listed with specific awards, but her academic and research profile clearly reflects recognition-worthy achievements. She graduated with honors (110/110 cum laude) in Medicine, which stands as an early testament to her dedication and excellence. Her first-author publications in indexed journals, such as Life, Medicina, Critical Care, and EJTM, highlight her as a leading contributor to translational and clinical research in anesthesiology and critical care. Her participation in international symposiums, including the 40th International Symposium on Intensive Care & Emergency Medicine, and collaborations with established experts like Prof. Navalesi, further underscore her growing reputation. While formal honors such as Best Researcher Awards are yet to be listed, her CV is aligned with the standards of excellence and would merit such recognition in academic and clinical research circles.

🔬 Research Focus:

Dr. Gagliardi’s research is deeply rooted in critical care medicine, with a strong emphasis on microcirculation, non-invasive ventilation, pain management, and echocardiographic imaging. Her work spans experimental and clinical domains—from animal models exploring systemic morphine’s anti-inflammatory effects, to human studies on ECMO efficiency and caudal epidural injections. She has delved into innovative diagnostics like diaphragm ultrasound for predicting extubation outcomes, and non-conventional therapies such as auricular electro-acupuncture for microcirculatory modulation. Her research extends into the perioperative and post-operative use of non-invasive respiratory support, and stress echocardiography, bridging imaging and intensive care management. She actively collaborates on multi-center reviews and pilot studies, showing both independence and teamwork. Dr. Gagliardi’s research consistently aims at improving patient outcomes through evidence-based and minimally invasive approaches, contributing significantly to the evolving landscape of modern anaesthesia and critical care.

📚 Publications Top Notes:

📄 The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
📄 Recirculation in Veno-Venous Extracorporeal Membrane Oxygenation
📄 A Possible Correlation Between Auricular Angiomas and Breast Cancer Through Auricular Acupuncture Diagnosis: An Observational Case-Control Study
📄 Ultrasound-guided caudal epidural injection to treat symptoms of lumbar spinal stenosis: a retrospective study
📄 Effects of noninvasive respiratory support in post-operative patients: a systematic review and network meta-analysis
📄 Systemic Morphine but Not Local Administration Shows Preventive Anti-Inflammatory Effect in a Rat Model of Capsaicin-Induced Paw Edema
📄 Effect of Low- and High-Frequency Auricular Stimulation with Electro-Acupuncture on Cutaneous Microcirculation: A Cross-Over Study in Healthy Subjects
📄 Diaphragm Ultrasound: A Valuable Predictor of the Outcome of Extubation. An Observational Pilot Study in Covid-19 Related ARDS
📄 Persistent neuropathic pain treated with Capsaicin patches: a novel promising approach
📄 P101 Execution of percutaneous dilatational tracheostomy using the standard laryngeal mask airway for ventilation: a prospective survey study
📄 Positive end-expiratory pressure titration in COVID-19 acute respiratory failure: electrical impedance tomography vs. PEEP/FiO2 tables

🧾 Conclusion:

Dr. Veronica Gagliardi is an exceptional emerging researcher who combines clinical acumen with a robust scientific mindset. Her research is innovative, clinically relevant, and methodologically sound, spanning critical areas like sepsis management, ECMO, echocardiography, and noninvasive ventilation strategies.

Raul Valenzuela | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Raul Valenzuela | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Raul Valenzuela , MD Anderson Cancer Center , United States

Dr. Raul F. Valenzuela Perez is a highly accomplished Assistant Professor of Musculoskeletal Imaging at The University of Texas MD Anderson Cancer Center. With over two decades of medical experience, he combines expertise in radiology, oncology, and advanced imaging techniques. Originating from Chile, Dr. Valenzuela earned his MD from Universidad de Chile and pursued advanced training in health administration and imaging sciences. His global perspective and collaborative research efforts have made him a prominent figure in musculoskeletal tumor imaging. He is board-certified in radiology in both the U.S. and Chile and is actively licensed in Texas and Florida. Dr. Valenzuela’s dedication to oncologic imaging, radiomics, and MRI innovations has resulted in numerous peer-reviewed publications, especially in the field of sarcoma imaging. Through ongoing work in developing and validating novel imaging biomarkers, he continues to shape the future of cancer diagnostics and personalized treatment approaches.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Prolific Research Output 📚
    Dr. Valenzuela has published extensively in high-impact journals like Scientific Reports, JCO Clinical Cancer Informatics, and Journal of Radiology & Oncology, with recent work in 2023–2025 focusing on radiomics, MRI biomarkers, and musculoskeletal oncology.

  2. Innovation in Imaging Techniques 💡
    He has pioneered the use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) and quantitative diffusion-weighted MRI to evaluate soft tissue sarcomas and treatment response — advancing imaging beyond traditional RECIST criteria.

  3. Collaborative Multidisciplinary Work 🤝
    Dr. Valenzuela consistently co-authors with surgical oncologists, pathologists, and radiologists, highlighting his collaborative research approach that bridges disciplines.

  4. International Clinical Credibility 🌎
    He is licensed in the U.S. (Texas & Florida) and Chile, and board-certified in both American and Chilean radiology boards, reflecting his global expertise and trust in varied medical systems.

  5. Academic Leadership at MD Anderson 🎓
    As an Assistant Professor at one of the world’s top cancer centers, he contributes to education, clinical care, and high-level cancer imaging research.

⚙️ Areas for Improvement:

  1. Recognition and Awards Disclosure 🏅
    While the publication record is impressive, public listing of prior individual awards, fellowships, or grants would strengthen his profile further for award consideration.

  2. Principal Investigator Roles 🧪
    Although highly involved in collaborative projects, leading major multi-center trials or imaging consortia as principal investigator would elevate his leadership status.

  3. Expanded Public Science Communication 🗣️
    Increasing outreach via conferences, keynote talks, or educational platforms (like webinars or radiology workshops) could enhance his visibility in the broader scientific community.

🎓 Education:

Dr. Raul F. Valenzuela Perez holds an MD from Universidad de Chile (1993), where he laid the foundation for his distinguished medical and academic career. Alongside his medical training, he pursued further specialization in healthcare management, earning two certificates from the University of Chile Business School: one in Business and Health Administration (2003) and another in Process Management and Health Administration (2005). This unique blend of medical and administrative education empowers Dr. Valenzuela with a strategic understanding of healthcare systems and leadership. His academic journey highlights a commitment to continuous learning and cross-disciplinary excellence. As a thought leader in radiologic sciences, Dr. Valenzuela has integrated his business knowledge with clinical expertise to enhance imaging workflows and patient-centered care, especially in high-impact cancer institutions like MD Anderson. His education reflects both clinical proficiency and managerial insight, laying the groundwork for his contributions to musculoskeletal oncology imaging.

🏥 Experience:

Since September 2019, Dr. Valenzuela has served as an Assistant Professor in Musculoskeletal Imaging at The University of Texas MD Anderson Cancer Center, one of the world’s leading cancer research institutions. Prior to his tenure in the U.S., he developed a robust clinical background in Chile, where he practiced and taught radiology. With licenses from the Texas Medical Board, Florida Medical Board, and Chilean Medical Association, his clinical credentials span internationally. He is also certified by the American Board of Radiology and the Chilean Radiology Board. At MD Anderson, Dr. Valenzuela plays a key role in advancing diagnostic imaging for musculoskeletal tumors, particularly soft tissue sarcomas. His responsibilities include patient care, teaching, research, and contributing to the development of advanced imaging protocols. Known for his collaborative style and interdisciplinary approach, he is a respected mentor and a valued contributor in the field of cancer imaging.

🏅 Awards and Honors:

While specific named awards are not detailed in the provided data, Dr. Raul F. Valenzuela Perez’s growing publication record, leading research in radiomics, and collaborative work at MD Anderson suggest a strong reputation in his field. His continuous publication in high-impact journals, such as Scientific Reports, JCO Clinical Cancer Informatics, and Journal of Radiology & Oncology, indicate recognition by peers and ongoing contributions to advancing cancer imaging. His role in multidisciplinary research teams and innovative use of advanced MRI techniques position him as a strong candidate for awards like Best Researcher. His efforts in improving imaging criteria beyond RECIST and validating AI-based radiomic frameworks show both vision and leadership. Though a detailed list of awards isn’t cited, his contributions to musculoskeletal oncology, particularly in sarcoma treatment response evaluation, reflect a track record of academic excellence and clinical impact, meriting honor and distinction in his specialty.

🔬 Research Focus:

Dr. Valenzuela’s primary research focus lies in advanced imaging for musculoskeletal oncology, particularly the integration of radiomics, perfusion-weighted MRI, and contrast-enhanced susceptibility-weighted imaging (CE-SWI) for tumor characterization and treatment monitoring. His work is centered on improving diagnosis and predicting response in soft-tissue sarcomas, such as undifferentiated pleomorphic sarcoma (UPS) and desmoid fibromatosis. He actively collaborates on multi-institutional studies, applying quantitative imaging biomarkers and AI-driven radiomic models to identify tumor behavior patterns and personalize therapy. A key aspect of his research is the evaluation of multiparametric MRI features, including diffusion-weighted and dynamic contrast-enhanced imaging. His publications reveal a commitment to pushing boundaries in functional imaging and improving imaging response criteria beyond traditional RECIST methods. Through his research, Dr. Valenzuela aims to contribute to precision medicine in oncology, bridging radiology and data science to enhance patient outcomes and streamline therapeutic decision-making.

📚 Publications Top Notes:

  1. 🧠 Perfusion-weighted imaging features predicting UPS treatment responseSci Rep, 2024

  2. 🧬 Radiomics by diffusion-weighted MRI for extremity UPS predictionJ Radiol Oncol, 2024

  3. 🧲 Contrast-enhanced SWI for musculoskeletal oncologic pathologyJ Radiol Oncol, 2024

  4. 💉 Perfusion imaging of the musculoskeletal systemMagn Reson Imaging Clin N Am, 2024

  5. 🤖 Cancer radiomic and perfusion imaging automated frameworkJCO Clin Cancer Inform, 2024

  6. 🧠 Idiopathic intracranial hypertension: MRI vs venous sinus pressureRev Chil Radiol, 2023

  7. 📊 CE-SWI in desmoid fibromatosis response assessmentTumor Discov, 2023

  8. 📈 Multiparametric MRI for treatment and recurrence in sarcomaJ Radiol Oncol, 2023

  9. 🔍 ADC map-based radiomics for sacral tumor differentiationJCO Precis Oncol, 2023

  10. 📐 Advanced imaging in musculoskeletal oncology (ABASTI Part I)Semin Ultrasound CT MR, 2021

  11. 🧪 Radiomic features of CE-SWI in UPS treatment responseJCO Clin Cancer Inform, 2025

📝 Conclusion:

Dr. Raul F. Valenzuela Perez is a highly deserving candidate for the Best Researcher Award. His innovative contributions to musculoskeletal oncologic imaging, especially in applying radiomic models and advanced MRI techniques, place him at the forefront of translational cancer imaging. His interdisciplinary collaborations and growing body of work have strong clinical impact, particularly for sarcoma management.

With additional visibility through PI roles and recognition through formal honors, Dr. Valenzuela’s already impressive profile is on a trajectory toward international distinction. Based on the current accomplishments and ongoing impactful research, he is highly recommended for this award.